Subgroup analysis according to NOS quality grade for RASSF1 illustrated that studies with a quality of more than 7 yielded more specific thyroid cancer risk factors (OR: 2.67) in comparison with low-quality studies (OR: 7.39). Here, RASSF1 is linked to thyroid gland carcinoma.